Press Release: Elsevier’s New ECC Webcasts Platform Provides Free Access to Webcasts of the European Cancer Congress
AMSTERDAM—January 21, 2016—A new online platform gives healthcare professionals free access to a selection of lectures from Europe’s biggest cancer conference, providing them with the latest research on a variety of cancers and treatments.
The ECC Webcasts platform (eccwebcasts.ejcancer.com), run by Elsevier and hosted by the European Journal of Cancer (EJC), features webcasts of some of the ECCO ESMO Industry Sponsored Satellite Symposia.
The European Cancer Congress (ECC2015), held in Vienna on 25-29 September 2015, was the largest European platform for presenting ground-breaking data to a global audience.
More than 19,000 oncology professionals attended the conference, which was split into 25 tracks and featured 634 invited speakers. 46 satellite symposia covered a variety of therapy areas, from therapeutic considerations in advanced renal cell carcinoma to targeting hypoxia to unlock new therapeutic opportunities for solid tumors.
The ECC Webcasts platform presents talks from a selection of these symposia as webcasts, so if a healthcare professional was unable to attend ECC2015, they can access some of the content online, free of charge.
“Healthcare professionals need to stay up-to-date with the latest research, but it’s not always possible for them to attend conferences, especially if they are far away,” said Giancarlo Pazzanese, project manager at Elsevier.
Each video is synchronized with the presenter’s slides, which viewers can download. The transcript of each lecture is also available. The content is fully interactive: clicking on any slide will skip the viewer to the corresponding point in the lecture.
It is also possible to search across all webcasts – the content is multi-therapy, so healthcare professionals can search for their area of interest in oncology to find the most relevant webcasts.
Symposia included on the ECC Webcasts platform:
- Therapeutic Considerations in Advanced Renal Cell Carcinoma: A Continuum of Care
- International Tumour Board: Case-Based Discussion of Real-World Clinical Management of Patients with Progressive Metastatic Colorectal Cancer
- Real-World Case Studies: What is Clinical Practice Telling Us? A Multidisciplinary Approach in Metastatic Castrate Resistant Prostate Cancer
- Metastatic Breast Cancer & Non-Small Cell Lung Cancer: Let's Talk About Disease Control
- Maximizing Clinical Management for Your Patients: Advances in Cancer Care with MKIs
- Targeting Hypoxia to Unlock New Therapeutic Opportunities for Solid Tumors
- The why, the which, and the how of targeting angiogenesis in GI malignancies
About the European Journal of Cancer
The European Journal of Cancer (EJC) is an international multidisciplinary oncology journal that publishes original research, reviews and editorial comments on basic and preclinical cancer research, translational oncology, clinical oncology and cancer epidemiology and prevention. The EJC is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European CanCer Organisation (ECCO), the European Association for Cancer Research (EACR) and the European Society of Breast Cancer Specialists (EUSOMA).
The European Cancer Congress (ECC2015), held in Vienna on 25-29 September 2015, was the largest European platform for presenting ground-breaking data to a global audience. More than 19,000 oncology professionals attended, representing more than 100 countries. 2,023 abstracts were accepted and presented in 25 conference tracks, including 634 invited speakers, 136 oral presentations and 1,849 posters. Held in partnership with ECCO, ESMO, ESTRO, ESSO, EACR, EONS and SIOPE, ECC2015 presented an abundance of practice-changing data.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries. www.elsevier.com